logo

For the Inventor, By the Inventor

Monza, Italy

Mario Riva

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Milan, IT (1980 - 1983)
  • Monza (Milan), IT (1977 - 1986)
  • Monza, IT (1981 - 1990)

Company Filing History:

goldMedal5 out of 25 
 
Pierrel Spa
 patents
silverMedal3 out of 3 
 
Maggioni-Winthrop S.p.a.
 patents
bronzeMedal2 out of 2 
 
Maggioni Farmaceutici, S.p.a.
 patents
4. 1 out of 832,966 
Other
 patents

Years Active: 1977-1990

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4902799 - Bicyclic alkoxy- and alkylthio-substituted aminoalcohols (1990-02-20),
2. 4826975 - Fused cycloaliphatic aminoalcohols (1989-05-02),
3. 4791104 - Dihydrobenzothiophene and thiochromane aminoalcohols (1988-12-13),
4. 4587248 - 4-alkyl-thiophenyl-ethanolamines, having an activity the cerebral (1986-05-06),
5. 4571401 - 3-Pyridine acetic and 3-(3-pyridyl-methoxycarbonyl)-propionic acid (1986-02-18),
6. 4460601 - Dipeptides having a methionine residue and possessing a protective (1984-07-17),
7. 4390533 - Steroids and process for preparing the same (1983-06-28),
8. 4275061 - Steroids and process for preparing the same (1981-06-23),
9. 4272446 - Steroids and process for preparing the same (1981-06-09),
10. 4226862 - Steroids and process for preparing the same (1980-10-07),
11. 4013679 - Substituted 6,7-dihydro [1,7-ab](1) benzazepine compounds (1977-03-22),

Title: The Innovative Contributions of Mario Riva

Introduction

Mario Riva is a renowned inventor located in Monza, Italy, recognized for his contributions to the field of pharmacological compounds with numerous innovations under his belt. With a notable total of 11 patents, Riva has made significant strides in the development of aminoalcohol derivatives that have substantial therapeutic applications.

Latest Patents

Among his most recent patents, Riva has developed innovative fused cycloaliphatic aminoalcohols. The invention focuses on compounds possessing pharmacological activity including anti-hypertensive properties, platelet aggregation inhibition, hypolipemic effects, antianoxic capabilities, and spasmolytic activities. The patented compounds follow a specific generic formula, where 'n' is an integer ranging from 1 to 2, thus belonging to the indanol and tetralol series.

Career Highlights

Mario Riva's professional journey includes collaborations with prominent companies such as Pierrel Spa and Maggioni-Winthrop S.p.A. These roles allowed him to refine his expertise and formulate groundbreaking inventions that have contributed to advancements in medical chemistry and pharmacology.

Collaborations

Throughout his career, Riva has worked alongside distinguished colleagues, including Giampaolo Picciola and Franco Ravenna. These professional collaborations exemplify the teamwork and ingenuity commonly found within the field of scientific research, leading to remarkable innovations and the successful patenting of new ideas.

Conclusion

Mario Riva's work exemplifies the spirit of innovation in the realm of pharmacology. His advancements in aminoalcohol derivatives and significant patents highlight the intersection of creativity and science. As he continues to contribute to the scientific community, Riva remains a key figure in the landscape of modern medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…